TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 70 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,118 | -84.8% | 1,276 | -84.7% | 0.00% | -100.0% |
Q2 2023 | $316,449 | +49.1% | 8,343 | -4.4% | 0.00% | – |
Q1 2023 | $212,192 | -16.5% | 8,725 | -0.3% | 0.00% | – |
Q4 2022 | $254,187 | -13.8% | 8,753 | -10.7% | 0.00% | -100.0% |
Q3 2022 | $295,000 | -19.2% | 9,805 | -2.8% | 0.00% | 0.0% |
Q2 2022 | $365,000 | -19.4% | 10,091 | -3.8% | 0.00% | 0.0% |
Q1 2022 | $453,000 | -9.8% | 10,487 | +4.4% | 0.00% | 0.0% |
Q4 2021 | $502,000 | -26.3% | 10,043 | -6.1% | 0.00% | 0.0% |
Q3 2021 | $681,000 | -15.0% | 10,696 | -4.0% | 0.00% | -50.0% |
Q2 2021 | $801,000 | -5.1% | 11,144 | -2.6% | 0.00% | 0.0% |
Q1 2021 | $844,000 | +0.6% | 11,447 | +0.1% | 0.00% | 0.0% |
Q4 2020 | $839,000 | +24.7% | 11,438 | -6.6% | 0.00% | 0.0% |
Q3 2020 | $673,000 | -17.7% | 12,252 | -0.4% | 0.00% | 0.0% |
Q2 2020 | $818,000 | +0.1% | 12,301 | -7.8% | 0.00% | -33.3% |
Q1 2020 | $817,000 | -35.6% | 13,336 | -7.5% | 0.00% | 0.0% |
Q4 2019 | $1,268,000 | +10.7% | 14,421 | -5.0% | 0.00% | 0.0% |
Q3 2019 | $1,145,000 | -0.5% | 15,177 | +12.5% | 0.00% | 0.0% |
Q2 2019 | $1,151,000 | +17.6% | 13,486 | +48.8% | 0.00% | 0.0% |
Q1 2019 | $979,000 | +13885.7% | 9,065 | +11091.4% | 0.00% | – |
Q4 2018 | $7,000 | +40.0% | 81 | +68.8% | 0.00% | – |
Q3 2018 | $5,000 | -61.5% | 48 | -57.9% | 0.00% | – |
Q2 2018 | $13,000 | -18.8% | 114 | -30.5% | 0.00% | – |
Q1 2018 | $16,000 | -84.3% | 164 | -83.2% | 0.00% | – |
Q4 2017 | $102,000 | -37.0% | 979 | -31.8% | 0.00% | -100.0% |
Q3 2017 | $162,000 | -51.5% | 1,436 | -51.9% | 0.00% | 0.0% |
Q2 2017 | $334,000 | +43.3% | 2,983 | +49.4% | 0.00% | 0.0% |
Q1 2017 | $233,000 | +89.4% | 1,997 | +71.1% | 0.00% | – |
Q4 2016 | $123,000 | -79.7% | 1,167 | -78.6% | 0.00% | -100.0% |
Q3 2016 | $605,000 | -26.6% | 5,466 | -3.4% | 0.00% | -33.3% |
Q2 2016 | $824,000 | +3.0% | 5,659 | +1.3% | 0.00% | 0.0% |
Q1 2016 | $800,000 | -5.9% | 5,588 | +1.5% | 0.00% | 0.0% |
Q4 2015 | $850,000 | -28.9% | 5,503 | -34.2% | 0.00% | -40.0% |
Q3 2015 | $1,195,000 | +8.9% | 8,357 | +9.5% | 0.01% | +25.0% |
Q2 2015 | $1,097,000 | +2.0% | 7,632 | +0.2% | 0.00% | 0.0% |
Q1 2015 | $1,075,000 | – | 7,620 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ISZO CAPITAL MANAGEMENT LP | 1,104,168 | $154,849,000 | 80.27% |
Consonance Capital Management LP | 378,372 | $53,063,000 | 7.89% |
Moab Capital Partners | 93,133 | $13,061,000 | 6.27% |
Greywolf Capital Management LP | 277,936 | $38,978,000 | 5.77% |
Perceptive Advisors | 301,333 | $42,260,000 | 4.15% |
Valentine Capital Asset Management, Inc. | 141,270 | $19,812,000 | 3.81% |
Raging Capital Management, LLC | 253,236 | $35,514,000 | 3.78% |
Ativo Capital Management LLC | 18,058 | $2,532,000 | 1.10% |
Geduld E E | 8,000 | $1,122,000 | 0.70% |
Assured Investment Management LLC | 192,389 | $26,981,000 | 0.46% |